April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Magnetomotive Optical Coherence Tomography For Detecting Magnetic Particles In The Posterior Segment Of The Live Mouse Eye
Author Affiliations & Notes
  • Hong Jiang
    Ophthalmology, University of Miami/Bascom Palmer Eye Institute, Miami, Florida
  • Manik Goel
    Ophthalmology, University of Miami/Bascom Palmer Eye Institute, Miami, Florida
  • Michael R. Wang
    Electrical and Computer Engineering, University of Miami, Miami, Florida
  • Bylon Lam
    Ophthalmology, University of Miami/Bascom Palmer Eye Institute, Miami, Florida
  • Sanjoy K. Bhattacharya
    Ophthalmology, University of Miami/Bascom Palmer Eye Institute, Miami, Florida
  • Meixiao Shen
    Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida
  • Jianhua Wang
    Ophthalmology, University of Miami/Bascom Palmer Eye Institute, Miami, Florida
  • Footnotes
    Commercial Relationships  Hong Jiang, None; Manik Goel, None; Michael R. Wang, None; Bylon Lam, None; Sanjoy K. Bhattacharya, None; Meixiao Shen, None; Jianhua Wang, None
  • Footnotes
    Support  NIH (3R01EY016112-04S1 to SKB,1R21EY021012-01 to JW), UM SAC Award (JW), NIH Center Grant P30 EY014801, Research to Prevent Blindness (RPB)
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4801. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hong Jiang, Manik Goel, Michael R. Wang, Bylon Lam, Sanjoy K. Bhattacharya, Meixiao Shen, Jianhua Wang; Magnetomotive Optical Coherence Tomography For Detecting Magnetic Particles In The Posterior Segment Of The Live Mouse Eye. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4801.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To test the hypothesis that magnetomotive optic coherence tomography (MMOCT) and magnetic particles will enable imaging of posterior eye structures of live mouse eyes and to determine whether protein-bound magnetic nanoparticles has discernable toxicity.

Methods: : A custom built, high speed and ultra-high resolution (~3 µm) MMOCT was developed for imaging biotin-coupled magnetic particles (100 nm and ~1 µm, 0.1 mM biotin in 0.7 µl injected volume) in mice eye by applying an external dynamic magnetic field gradient. The magnetomotive signals were acquired by subtracting the images obtained with and without magnetic filed. Magnetic beads were imaged in vitro by embedded within agarose gel (1.5%) and in vivo in a congenic DBA/2J (D2-Gpnmb+-Sj/J mice) mouse eye. To assess toxicity and metabolic enzymatic activities (aldolase, pyruvate kinase, and malate dehyrogenase) of cell extracts were determined after incubation of primary retinal ganglion cells with magnetic particles. Three batches of 5000 cells each with 1 mM estimated biotin containing particles were used for these experiments

Results: : The MMOCT signals were successfully captured in the agarose gel with embedded magnetic beads. The MMOCT signals were also captured in the posterior segment of the mouse eyes after injecting the beads into the posterior chamber near the retina, and the signals were overlaid successfully onto the structural OCT image. The enzymatic assays of extracts from control and cells incubated with magnetic particles show no difference in activities suggesting lack of metabolic toxicity.

Conclusions: : To our knowledge, this is the first demonstration on the detection of particles injected into the posterior chamber of the mouse eye using MMOCT. This modality of imaging has the promise in studying optical neuritis and other posterior segment diseases. The novel method is expected to advance translational research.

Keywords: imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • retina • imaging/image analysis: non-clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×